FWD Group (1828) Q4 2025 (Q&A) earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 (Q&A) earnings summary
18 Mar, 2026Executive summary
Achieved record financial results in 2025, driven by organic growth across 10 Asian markets, notably Hong Kong, Japan, and Thailand, and successful execution of strategic initiatives.
Listed on HKEX, raising HK$3.6B (US$466m), and refinanced US$1.15B, reducing annual debt servicing cost by over 25%.
Moody's upgraded insurer financial strength rating to A2 and Fitch revised outlook to Positive.
Expense overruns have been addressed in major markets, with only emerging markets still closing the gap.
Margins in Hong Kong and Macau remain highly sustainable, supported by growth in the UHNW segment.
Financial highlights
New business sales (APE) grew 25% year-over-year to $2,446m; new business CSM up 18% to $1,476m.
Net UFSG grew 20% year-over-year in 2025, reflecting strong operating leverage and disciplined expense management.
Operating profit after tax rose 5% to $499m; net profit after tax surged 411% to $166m.
Group embedded value increased 19% to $6.9bn; comprehensive tangible equity up 18% to $8.7bn.
Agency productivity improved by 40% across the group, driven by digital enablement.
Outlook and guidance
Expect continued growth in 2026, with moderate growth in Hong Kong and strong momentum in Japan and emerging markets.
Key value metrics expected to grow by mid-teen percentages, with sustainable value creation and efficiency gains anticipated.
No impact expected to financial flexibility from Japan ESR implementation; stable group capital ratios projected.
Regulatory changes in Hong Kong mainly impact the retail broker channel, while the high net worth segment remains resilient.
Thailand anticipates moderate new business sales growth, with ongoing focus on pruning less profitable segments.
Latest events from FWD Group
- Record new business growth, strong capital, and digital innovation drive robust results.1828
Q2 202518 Mar 2026 - Record-breaking 2025 profit, 25% APE growth, and strong gains in Hong Kong and emerging markets.1828
Q4 202518 Mar 2026 - Record new business growth and strong capital position following successful IPO.1828
Q2 2025 (Q&A)18 Mar 2026 - Double-digit new business growth and robust solvency, but net loss from market volatility.1828
Q2 202418 Mar 2026 - VNB up 16% and new business sales up 13% year-on-year, driven by broad segment growth.1828
Q3 202418 Mar 2026 - Delivered first net profit under IFRS 17, strong growth in all segments, and robust capital position.1828
Q4 202418 Mar 2026 - Q1 2025 new business CSM up 55% and APE up 46%, led by strong Asian market demand.1828
Q1 202518 Mar 2026 - New business sales surged 37% and leverage improved to 21.8% after refinancing actions.1828
Q3 202518 Mar 2026